Article
New Products & Services
FDA OKs treatment for men with testosterone deficiency. Livingston, NJ-The FDA has approved Columbia Laboratories' testosterone buccal system (Striant mucoadhesive) for testosterone replacement therapy. The transbuccal treatment is for men with conditions associated with a deficiency or absence of endogenous testosterone, including hypogonadism.
Related Videos
Timothy Lyon, MD, on recent change to outpatient complications metric in urology rankings
Jason Hafron, MD, considers the future for AI in urology
Timothy Lyon, MD, highlights study assessing accuracy of urology rankings
Expert discusses feasibility of at-home inpatient urologic care
Tania Solomon, PA-C, highlights APP fellowship in urology
The benefits of working with a consultant when starting a private urology practice
Mark Edney, MD, on 3 key principles that improve job satisfaction
Amy Pearlman, MD, and Gia Ching on building a personal brand in urology
Chad Ritenour, MD, on efforts to promote physician well-being at Emory Urology
Mark Edney, MD, on creating a collaborative culture with APPs in urology
Related Content
